These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

768 related articles for article (PubMed ID: 26201484)

  • 1. Nanocarriers Based Anticancer Drugs: Current Scenario and Future Perceptions.
    Raj R; Mongia P; Kumar Sahu S; Ram A
    Curr Drug Targets; 2016; 17(2):206-28. PubMed ID: 26201484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in Nanocarriers for Anticancer Drugs Delivery.
    Ali I; Lone MN; Suhail M; Mukhtar SD; Asnin L
    Curr Med Chem; 2016; 23(20):2159-87. PubMed ID: 27048343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanocarriers for anticancer drugs--new trends in nanomedicine.
    Drbohlavova J; Chomoucka J; Adam V; Ryvolova M; Eckschlager T; Hubalek J; Kizek R
    Curr Drug Metab; 2013 Jun; 14(5):547-64. PubMed ID: 23687925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innovative nano-carriers in anticancer drug delivery-a comprehensive review.
    Dong P; Rakesh KP; Manukumar HM; Mohammed YHE; Karthik CS; Sumathi S; Mallu P; Qin HL
    Bioorg Chem; 2019 Apr; 85():325-336. PubMed ID: 30658232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sugar-based amphiphilic polymers for biomedical applications: from nanocarriers to therapeutics.
    Gu L; Faig A; Abdelhamid D; Uhrich K
    Acc Chem Res; 2014 Oct; 47(10):2867-77. PubMed ID: 25141069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring.
    Namiki Y; Fuchigami T; Tada N; Kawamura R; Matsunuma S; Kitamoto Y; Nakagawa M
    Acc Chem Res; 2011 Oct; 44(10):1080-93. PubMed ID: 21786832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanocarriers as an emerging platform for cancer therapy.
    Peer D; Karp JM; Hong S; Farokhzad OC; Margalit R; Langer R
    Nat Nanotechnol; 2007 Dec; 2(12):751-60. PubMed ID: 18654426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Research progress of novel inorganic nanometre materials carriers in nanomedicine for cancer diagnosis and treatment.
    Xu J; Liao K; Jiang H; Zhou W
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S492-S502. PubMed ID: 30449177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted multifunctional lipid-based nanocarriers for image-guided drug delivery.
    Koning GA; Krijger GC
    Anticancer Agents Med Chem; 2007 Jul; 7(4):425-40. PubMed ID: 17630918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanotechnology platforms and physiological challenges for cancer therapeutics.
    Kim KY
    Nanomedicine; 2007 Jun; 3(2):103-10. PubMed ID: 17442621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer chemotherapy with lipid-based nanocarriers.
    Liu D; Zhang N
    Crit Rev Ther Drug Carrier Syst; 2010; 27(5):371-417. PubMed ID: 21083528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted pharmaceutical nanocarriers for cancer therapy and imaging.
    Torchilin VP
    AAPS J; 2007 May; 9(2):E128-47. PubMed ID: 17614355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasound-Mediated Cancer Therapeutics Delivery using Micelles and Liposomes: A Review.
    Mukhopadhyay D; Sano C; AlSawaftah N; El-Awady R; Husseini GA; Paul V
    Recent Pat Anticancer Drug Discov; 2021; 16(4):498-520. PubMed ID: 34911412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An insight into the dual role of MoS2-based nanocarriers in anticancer drug delivery and therapy.
    Ghosh S; Lai JY
    Acta Biomater; 2024 Apr; 179():36-60. PubMed ID: 38552760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applications of nanosystems to anticancer drug therapy (Part II. Dendrimers, micelles, lipid-based nanosystems).
    Ruiz ME; Gantner ME; Talevi A
    Recent Pat Anticancer Drug Discov; 2014 Jan; 9(1):99-128. PubMed ID: 23578193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanomedicine: Innovative Strategies and Recent Advances in Targeted Cancer Therapy.
    Gautam RK; Mittal P; Goyal R; Dua K; Mishra DK; Sharma S; Singla RK
    Curr Med Chem; 2024; 31(28):4479-4494. PubMed ID: 37828674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanotechnological carriers for cancer chemotherapy: the state of the art.
    Estanqueiro M; Amaral MH; Conceição J; Sousa Lobo JM
    Colloids Surf B Biointerfaces; 2015 Feb; 126():631-48. PubMed ID: 25591851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of multifunctional nanocarriers for delivery of anti-cancer therapy.
    Mehra NK; Jain K; Jain NK
    Curr Pharm Des; 2015; 21(42):6157-64. PubMed ID: 26503145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives.
    Edis Z; Wang J; Waqas MK; Ijaz M; Ijaz M
    Int J Nanomedicine; 2021; 16():1313-1330. PubMed ID: 33628022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.